FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1857702564> ?p ?o ?g. }

• W1857702564 endingPage "70" @default.
• W1857702564 startingPage "261" @default.
• W1857702564 abstract "To evaluate the potential effectiveness of the application of mupirocin ointment at the catheter exit site in preventing exit-site infection and peritonitis caused by Staphylococcus aureus (SA).This prospective, historically controlled study was done on 181 peritoneal dialysis patients treated between 1 November 1996 and 1 November 1997. They were instructed to apply mupirocin at the catheter exit site daily or three times per week at the conclusion of their exit-site care (Study 1). The patients were not screened to determine whether they were SA carriers. The group's historical control was the infection data from the previous year among these patients. A second group of 70 patients, who started using mupirocin within a month after catheter implantation (1996-1997), was compared with a historical group of 118 patients (controls) who were on continuous ambulatory peritoneal dialysis (CAPD) for 1 year after in-patient implantation without mupirocin, (1990-1995) (Study 2).In the group of 181 patients (Study 1), application of mupirocin at the exit site led to a significant reduction in SA exit-site infections--21 versus 3 episodes (0.11 vs 0.01 episodes/patient/year)--and a significant reduction of SA peritonitis--35 episodes in the year preceding mupirocin versus 11 episodes during the year of mupirocin treatment (0.19 vs 0.06 ep/pt/yr). The same results were observed in Study 2: the incidence of SA exit-site infection was significantly lower in the mupirocin-treated group--17 episodes among the 118 nontreated patients versus 4 episodes among 70 patients using mupirocin (0.14 ep/pt/yr vs 0.06 ep/pt/yr, respectively). Similarly there were 20 episodes of SA peritonitis among 118 patients during their first year of CAPD versus 4 episodes in 70 mupirocin-treated patients (0.16 ep/pt/yr vs 0.06 ep/pt/yr, respectively). No adverse effects were observed among the patients treated with mupirocin. Overall peritonitis rates decreased from 0.87 to 0.48 ep/pt/yr (p < 0.01) in Study 1 and from 0.56 to 0.41 ep/pt/yr (p = NS) in Study 2. We observed no differences in the incidence of exit-site infection and peritonitis rates among patients applying mupirocin ointment at the exit site daily, compared to three times per week.Mupirocin application at the exit site significantly lowers the incidence of SA exit-site infections and peritonitis due to SA infections. Since SA infections are accompanied by significant morbidity and occasional mortality, this treatment may improve long-term survival of patients on CAPD." @default.
• W1857702564 created "2016-06-24" @default.
• W1857702564 creator A5024107444 @default.
• W1857702564 creator A5030512435 @default.
• W1857702564 creator A5065799414 @default.
• W1857702564 creator A5077925736 @default.
• W1857702564 creator A5087812904 @default.
• W1857702564 creator A5088114673 @default.
• W1857702564 date "1998-07-15" @default.
• W1857702564 modified "2023-09-23" @default.
• W1857702564 title "Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site." @default.
• W1857702564 cites W113631281 @default.
• W1857702564 cites W1834509525 @default.
• W1857702564 cites W1899297592 @default.
• W1857702564 cites W1965198375 @default.
• W1857702564 cites W1966664751 @default.
• W1857702564 cites W1975273520 @default.
• W1857702564 cites W1991734539 @default.
• W1857702564 cites W1997170892 @default.
• W1857702564 cites W1997280355 @default.
• W1857702564 cites W2002343762 @default.
• W1857702564 cites W2013131697 @default.
• W1857702564 cites W2020674409 @default.
• W1857702564 cites W2021049127 @default.
• W1857702564 cites W2031087934 @default.
• W1857702564 cites W2032956703 @default.
• W1857702564 cites W2037015678 @default.
• W1857702564 cites W2041128453 @default.
• W1857702564 cites W2041202006 @default.
• W1857702564 cites W2050586165 @default.
• W1857702564 cites W2059826538 @default.
• W1857702564 cites W2085339757 @default.
• W1857702564 cites W2096904100 @default.
• W1857702564 cites W2097465167 @default.
• W1857702564 cites W2110038661 @default.
• W1857702564 cites W2111113492 @default.
• W1857702564 cites W2120370659 @default.
• W1857702564 cites W2132213225 @default.
• W1857702564 cites W2155336775 @default.
• W1857702564 cites W2158542296 @default.
• W1857702564 cites W2164843611 @default.
• W1857702564 cites W2188531823 @default.
• W1857702564 cites W2413755255 @default.
• W1857702564 cites W2413803924 @default.
• W1857702564 cites W2519385416 @default.
• W1857702564 cites W2730072590 @default.
• W1857702564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9663889" @default.
• W1857702564 hasPublicationYear "1998" @default.
• W1857702564 type Work @default.
• W1857702564 sameAs 1857702564 @default.
• W1857702564 citedByCount "37" @default.
• W1857702564 countsByYear W18577025642012 @default.
• W1857702564 countsByYear W18577025642013 @default.
• W1857702564 countsByYear W18577025642014 @default.
• W1857702564 countsByYear W18577025642015 @default.
• W1857702564 countsByYear W18577025642016 @default.
• W1857702564 countsByYear W18577025642017 @default.
• W1857702564 countsByYear W18577025642019 @default.
• W1857702564 countsByYear W18577025642020 @default.
• W1857702564 crossrefType "journal-article" @default.
• W1857702564 hasAuthorship W1857702564A5024107444 @default.
• W1857702564 hasAuthorship W1857702564A5030512435 @default.
• W1857702564 hasAuthorship W1857702564A5065799414 @default.
• W1857702564 hasAuthorship W1857702564A5077925736 @default.
• W1857702564 hasAuthorship W1857702564A5087812904 @default.
• W1857702564 hasAuthorship W1857702564A5088114673 @default.
• W1857702564 hasConcept C120665830 @default.
• W1857702564 hasConcept C121332964 @default.
• W1857702564 hasConcept C126322002 @default.
• W1857702564 hasConcept C141071460 @default.
• W1857702564 hasConcept C188816634 @default.
• W1857702564 hasConcept C2777052132 @default.
• W1857702564 hasConcept C2777334864 @default.
• W1857702564 hasConcept C2778246068 @default.
• W1857702564 hasConcept C2779056158 @default.
• W1857702564 hasConcept C2779489039 @default.
• W1857702564 hasConcept C2780199535 @default.
• W1857702564 hasConcept C2781267111 @default.
• W1857702564 hasConcept C2909406889 @default.
• W1857702564 hasConcept C3020484687 @default.
• W1857702564 hasConcept C35785553 @default.
• W1857702564 hasConcept C523546767 @default.
• W1857702564 hasConcept C54355233 @default.
• W1857702564 hasConcept C61511704 @default.
• W1857702564 hasConcept C71924100 @default.
• W1857702564 hasConcept C86803240 @default.
• W1857702564 hasConceptScore W1857702564C120665830 @default.
• W1857702564 hasConceptScore W1857702564C121332964 @default.
• W1857702564 hasConceptScore W1857702564C126322002 @default.
• W1857702564 hasConceptScore W1857702564C141071460 @default.
• W1857702564 hasConceptScore W1857702564C188816634 @default.
• W1857702564 hasConceptScore W1857702564C2777052132 @default.
• W1857702564 hasConceptScore W1857702564C2777334864 @default.
• W1857702564 hasConceptScore W1857702564C2778246068 @default.
• W1857702564 hasConceptScore W1857702564C2779056158 @default.
• W1857702564 hasConceptScore W1857702564C2779489039 @default.
• W1857702564 hasConceptScore W1857702564C2780199535 @default.
• W1857702564 hasConceptScore W1857702564C2781267111 @default.

• next